Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and Hypophosphatemia

tenofovir has been researched along with Hypophosphatemia in 41 studies

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (31.71)29.6817
2010's22 (53.66)24.3611
2020's6 (14.63)2.80

Authors

AuthorsStudies
Baek, JH; Hahm, JR; Jung, J; Jung, JH; Kim, H; Kim, KY; Kim, MY; Kim, SK; Kim, Y; Shin, Y1
Han, BH; Jeong, J; Lee, D; Lee, JW; Lee, SU; Park, ET; Seo, KI; Yun, BC1
Hooi, B; Leungsuwan, S; Myint, KS1
Byakika-Kibwika, P; Kalyesubula, R; Nyende, L; Sekasanvu, E1
Bloch, M; Gracey, DM; Heron, JE; Saunders, J; Vanguru, V1
Behrens, GMN; Sandmann, L; Stoll, M1
Iatan, I; Lee, TC; McDonald, EG1
Chen, CL; Chen, NC; Chung, TL1
Güner, R; Koçak Tufan, Z; Mehmet A, T; Yılmaz, GR1
Fujii, T; Kawasoe, K; Nitta, K; Ohta, A1
Ackers, ML; Buchbinder, SP; Chillag, KL; Collins, BM; Grant, RM; Grohskopf, LA; Gvetadze, R; Liu, AY; Mayer, KH; Oʼhara, B; Pathak, SR; Paxton, LA; Rose, CE; Thompson, M1
Funk, EK; Heytens, L; Kohli, A; Kottilil, S; Kwan, R; Masur, H; Nelson, A; Polis, MA; Shaffer, A; Shivakumar, B; Sneller, M1
Dorrell, L; Duncan, S; Sherrard, J; Shine, B; Wainwright, E1
Amann, K; Bickel, M; Brodt, HR; Buettner, M; Geiger, H; Gute, P; Haberl, A; Jung, O; Khaykin, P; Lutz, T; Schmidt, K; Stephan, C1
Baker, A; Bethel, J; Flynn, PM; Gordon, CM; Havens, PL; Hazra, R; Kapogiannis, BG; Kiser, JJ; Liu, N; Lujan-Zilbermann, J; Mulligan, K; Pan, CG; Rutledge, B; Stephensen, CB; Van Loan, MD; Wilson, CM; Woodhouse, LR1
Becker, CB; Hamnvik, OP; Levy, BD; Loscalzo, J1
Holmes, DT; Jiang, SY; Kendler, DL; Saeedi, R1
Bonjoch, A; Holgado, S; Mariñoso, ML; Mateo, L; Olivé, A; Pérez-Andrés, R; Romeu, J1
Foster, C; Lim, Y; Lyall, H1
Bourlière, M; Cadranel, JF; Causse, X; Consoli, SM; Dumortier, J; Hézode, C; Larrey, D; Libert, O; Marcellin, P; Ouzan, D; Pageaux, GP; Pauwels, A; Pétour, P; Riachi, G; Roche, B; Stern, C; Tilliet, V; Truchi, R; Zarski, JP; Zoulim, F1
Chang, SY; Cheng, CY; Cheng, SH; Ku, SY; Lin, MH; Sun, NL1
Chen, Y; Ding, H; Han, Y; Liao, H; Liu, Y; Zeng, A1
Andrade, L; Libório, AB; Pereira, LV; Sanches, TR; Seguro, AC; Shimizu, MH1
Chatelut, E; Jaafar, A; Malard, L; Massip, P; Séronie-Vivien, S; Tack, I1
Kaplan, BS; Meyers, KE; Rutstein, RM; Shah, SS; Steenhoff, AP; Wood, SM1
Barril Cuadrado, G; de Los Santos Gil, I1
Boyd, KL; Butler, K; Dunn, D; Gibb, DM; Judd, A; Lyall, H; Riordan, A; Sharland, M; Shingadia, D; Stöhr, W1
Boissier, MC; Prendki, V; Prie, D; Saidenberg-Kermanac'h, N; Souabni, L1
León, E; Lozano de León-Naranjo, F; Pérez-Rivera, AÁ; Sáez, P1
Bower, M; Kumar, N; Nelson, M1
Bech, A; De Boer, H; Gisolf, J; Nabbe, K; Richter, C; Van Bentum, P1
Attia, S; Bogner, JR; Füeßl, B; Goebel, FD; Kay, L; Lederer, SR; Röder, M; Schlattner, U; Schmid, H; Tokarska-Schlattner, M1
Daniel, N; de Boever, CM; Leray, H; Mauboussin, JM; Moachon, L; Peyrière, H; Reynes, J; Rouanet, I; Salmon-Céron, D; Vincent, D1
Alexandre, M; Breton, G; Duval, X; Leport, C; Peytavin, G; Prie, D; Vildei, JL1
Bannister, A; Day, SL; Fisher, M; Hankins, M; Leake Date, HA1
Antoniou, T; Chirhin, S; Gough, K; Govan, V; Loutfy, M; Raboud, J; Rachlis, A; Yoong, D1
Fine, DM1
Issa, BG; Parsonage, MJ; Savage, MW; Snowden, N; Wilkins, EG1
Badiou, S; Baillat, V; Cristol, JP; De Boever, CM; Reynes, J; Terrier, N1
Baker, RK; Brooks, JT; Buchacz, K; Greenberg, A; Holmberg, SD; Moorman, AC; Tong, T1
Cabau, J; Gort, A; Planella, R; Roselló, L1

Reviews

4 review(s) available for tenofovir and Hypophosphatemia

ArticleYear
The efficacy and safety comparison between tenofovir and entecavir in treatment of chronic hepatitis B and HBV related cirrhosis: A systematic review and Meta-analysis.
    International immunopharmacology, 2017, Volume: 42

    Topics: Acute Kidney Injury; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Hypophosphatemia; Liver Cirrhosis; Tenofovir; Treatment Outcome; Viral Load

2017
Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males.
    AIDS patient care and STDs, 2009, Volume: 23, Issue:1

    Topics: Adenine; Adolescent; Age Factors; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Black or African American; Blood Urea Nitrogen; CD4 Lymphocyte Count; Creatinine; Diagnosis, Differential; HIV Infections; Humans; Hypophosphatemia; Infectious Disease Transmission, Vertical; Male; Organophosphonates; Renal Insufficiency; Reverse Transcriptase Inhibitors; Rickets; Risk Factors; Safety; Tenofovir

2009
[Management of renal toxicity in HIV-positive patients. What to measure, how to measure it and how frequently].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 8

    Topics: Adenine; Algorithms; Anti-HIV Agents; beta 2-Microglobulin; Clinical Trials as Topic; Cohort Studies; Creatinine; Drug Monitoring; Female; HIV Infections; Humans; Hypophosphatemia; Incidence; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Male; Organophosphonates; Proteinuria; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors

2008
Editorial comment: tenofovir nephrotoxicity--vigilance required.
    The AIDS reader, 2005, Volume: 15, Issue:7

    Topics: Adenine; Fanconi Syndrome; Glycosuria; HIV Infections; Humans; Hypokalemia; Hypophosphatemia; Organophosphonates; Proteinuria; Renal Insufficiency; Reverse Transcriptase Inhibitors; Tenofovir

2005

Trials

4 trial(s) available for tenofovir and Hypophosphatemia

ArticleYear
Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States.
    Journal of acquired immune deficiency syndromes (1999), 2013, Sep-01, Volume: 64, Issue:1

    Topics: Adenine; Adolescent; Anti-HIV Agents; Boston; CD4 Lymphocyte Count; Double-Blind Method; Follow-Up Studies; Georgia; HIV Infections; HIV Seronegativity; Homosexuality, Male; Humans; Hypophosphatemia; Male; Medication Adherence; Middle Aged; Organophosphonates; San Francisco; Tenofovir; Treatment Outcome

2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11

    Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Calcitriol; Calcium; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; HIV; HIV Infections; Humans; Hypophosphatemia; Male; Organophosphonates; Parathyroid Hormone; Phosphates; Reverse Transcriptase Inhibitors; Tenofovir; Vitamin D Deficiency; Vitamin D-Binding Protein

2013
Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:11

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Creatinine; Female; HIV Infections; HIV-1; Humans; Hypophosphatemia; Male; Phosphates; Prospective Studies; Tenofovir

2016
Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
    The Journal of infection, 2006, Volume: 52, Issue:5

    Topics: Adenine; Adult; Anti-HIV Agents; Cross-Sectional Studies; Female; HIV Infections; Humans; Hypophosphatemia; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Phosphates; Tenofovir

2006

Other Studies

33 other study(ies) available for tenofovir and Hypophosphatemia

ArticleYear
Glucocorticoid-Induced Hypokalemic Periodic Paralysis after Short-Term Use of Tenofovir with Hypophosphatemia: A Case Report.
    Medicina (Kaunas, Lithuania), 2021, Dec-30, Volume: 58, Issue:1

    Topics: Adult; Glucocorticoids; Humans; Hypokalemia; Hypokalemic Periodic Paralysis; Hypophosphatemia; Male; Tenofovir

2021
Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate.
    Medicine, 2019, Volume: 98, Issue:50

    Topics: Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Hypophosphatemia; Male; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Tenofovir; Treatment Outcome

2019
Hypophosphatemic Osteomalacia Due to Adefovir-Induced Fanconi Syndrome.
    The American journal of medicine, 2020, Volume: 133, Issue:12

    Topics: Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Female; Hepatitis C, Chronic; Humans; Hypophosphatemia; Organophosphonates; Osteomalacia; Tenofovir

2020
Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study.
    BMC nephrology, 2020, 06-22, Volume: 21, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glycosuria; HIV Infections; Humans; Hypercalcemia; Hyperkalemia; Hyperphosphatemia; Hypocalcemia; Hypokalemia; Hypophosphatemia; Lamivudine; Male; Middle Aged; Prevalence; Proteinuria; Renal Insufficiency; Tenofovir; Uganda

2020
Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report.
    BMC nephrology, 2020, 08-12, Volume: 21, Issue:1

    Topics: Acute Disease; Alanine; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chemotherapy-Induced Febrile Neutropenia; Deprescriptions; Drug Interactions; Fanconi Syndrome; Gentamicins; Glycosuria; HIV Infections; Hodgkin Disease; Humans; Hypokalemia; Hypophosphatemia; Male; Middle Aged; Proteinuria; Tenofovir

2020
Hypophosphatemia in people with HIV: no benefit when switching from tenofovir disoproxil fumarate to tenfovir alafenamide.
    AIDS (London, England), 2021, 07-15, Volume: 35, Issue:9

    Topics: Anti-HIV Agents; Fumarates; HIV Infections; Humans; Hypophosphatemia; Retrospective Studies; Tenofovir

2021
Tenofovir-induced osteomalacia with hypophosphataemia.
    BMJ case reports, 2021, May-24, Volume: 14, Issue:5

    Topics: Antiviral Agents; Fanconi Syndrome; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Hypophosphatemia; Middle Aged; Osteomalacia; Tenofovir

2021
Severe hypophosphatemia induced by denosumab in a patient with osteomalacia and tenofovir disoproxil fumarate-related acquired Fanconi syndrome.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2019, Volume: 30, Issue:2

    Topics: Antiviral Agents; Bone Density Conservation Agents; Denosumab; Fanconi Syndrome; Fractures, Stress; Hepatitis B, Chronic; Humans; Hypophosphatemia; Male; Middle Aged; Osteomalacia; Radiography; Radionuclide Imaging; Tenofovir; Tibial Fractures; Tomography, X-Ray Computed

2019
Tenofovir disoproxil fumarate may not cause renal and bone toxicity in chronic hepatitis B patients: a retrospective cross-sectional study
    Turkish journal of medical sciences, 2019, 02-11, Volume: 49, Issue:1

    Topics: Antiviral Agents; Bone Density; Calcium; Cross-Sectional Studies; Glomerular Filtration Rate; Hepatitis B, Chronic; Humans; Hypocalcemia; Hypophosphatemia; Phosphates; Retrospective Studies; Tenofovir

2019
A case of entecavir-induced Fanconi syndrome.
    CEN case reports, 2019, Volume: 8, Issue:4

    Topics: Acidosis; Acute Kidney Injury; Adenine; Aged; Alanine; Antiviral Agents; Fanconi Syndrome; Guanine; Hepatitis B, Chronic; Humans; Hypokalemia; Hypophosphatemia; Male; Nucleosides; Tenofovir; Treatment Outcome; Withholding Treatment

2019
Short communication: Interferon/ribavirin treatment for HCV is associated with the development of hypophosphatemia in HIV/hepatitis C virus-coinfected patients.
    AIDS research and human retroviruses, 2013, Volume: 29, Issue:9

    Topics: Adenine; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Drug Interactions; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Hypophosphatemia; Interferons; Kidney Diseases; Male; Middle Aged; Organophosphonates; Retrospective Studies; Ribavirin; Risk Factors; Tenofovir

2013
Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
    International journal of STD & AIDS, 2013, Volume: 24, Issue:7

    Topics: Adenine; Adult; Anti-Retroviral Agents; Cross-Sectional Studies; Female; Glomerular Filtration Rate; HIV Infections; Hospitals, Teaching; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Phosphates; Prevalence; Prospective Studies; Risk Factors; Tenofovir; Treatment Outcome; United Kingdom

2013
Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
    HIV medicine, 2013, Volume: 14, Issue:10

    Topics: Acute Kidney Injury; Adenine; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Interactions; Fanconi Syndrome; Female; Germany; HIV Infections; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir

2013
Clinical problem-solving. Wasting away.
    The New England journal of medicine, 2014, Mar-06, Volume: 370, Issue:10

    Topics: Adenine; Adult; Bone Diseases, Metabolic; Cachexia; Diagnosis, Differential; Fanconi Syndrome; Female; Hepatitis B; Humans; Hypophosphatemia; Liver Function Tests; Organophosphonates; Pelvic Bones; Phosphates; Radiography; Reverse Transcriptase Inhibitors; Tenofovir

2014
Fibroblast growth factor 23 is elevated in tenofovir-related hypophosphatemia.
    Calcified tissue international, 2014, Volume: 94, Issue:6

    Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Fanconi Syndrome; Fibroblast Growth Factor-23; Fibroblast Growth Factors; HIV Infections; Humans; Hypophosphatemia; Male; Organophosphonates; Osteomalacia; Osteoporosis; Tenofovir

2014
Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients.
    Clinical rheumatology, 2016, Volume: 35, Issue:5

    Topics: Adult; Anti-HIV Agents; Bone and Bones; Female; HIV Infections; Humans; Hypophosphatemia; Magnetic Resonance Imaging; Male; Middle Aged; Osteomalacia; Tenofovir

2016
Tenofovir-Associated Nephrotoxicity in Children with Perinatally-Acquired HIV Infection: A Single-Centre Cohort Study.
    Clinical drug investigation, 2015, Volume: 35, Issue:5

    Topics: Adolescent; Anti-HIV Agents; Child; Female; HIV Infections; Humans; Hypokalemia; Hypophosphatemia; Kidney Diseases; Male; Retrospective Studies; Tenofovir

2015
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:10

    Topics: Abdominal Pain; Adult; Aged; Antiviral Agents; Asthenia; Diarrhea; DNA, Viral; Female; France; Headache; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Hypophosphatemia; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Nausea; Prospective Studies; Seroconversion; Tenofovir; Treatment Outcome; Viral Load; Vomiting

2016
Rosiglitazone reverses tenofovir-induced nephrotoxicity.
    Kidney international, 2008, Volume: 74, Issue:7

    Topics: Adenine; Animals; Drug-Related Side Effects and Adverse Reactions; Glomerular Filtration Rate; Hypoglycemic Agents; Hypophosphatemia; Hypophosphatemia, Familial; Kidney Diseases; Male; Membrane Transport Proteins; Organophosphonates; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Rosiglitazone; Tenofovir; Thiazolidinediones

2008
Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
    AIDS (London, England), 2009, Jan-14, Volume: 23, Issue:2

    Topics: Adenine; Anti-HIV Agents; Biomarkers; Creatinine; Cystatin C; Fanconi Syndrome; HIV Infections; Humans; Hypophosphatemia; Organophosphonates; Retrospective Studies; Sensitivity and Specificity; Tenofovir

2009
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
    AIDS (London, England), 2010, Feb-20, Volume: 24, Issue:4

    Topics: Adenine; Adolescent; Anti-HIV Agents; Case-Control Studies; Child; Child, Preschool; England; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Hypophosphatemia; Ireland; Kidney; Male; Organophosphonates; Salvage Therapy; Tenofovir; Treatment Outcome

2010
Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease.
    Joint bone spine, 2011, Volume: 78, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adenine; Adult; Anti-HIV Agents; Drug Substitution; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypophosphatemia; Male; Neurofibromatosis 1; Organophosphonates; Osteomalacia; Phosphates; Pyrrolidinones; Raltegravir Potassium; Tenofovir; Treatment Outcome

2011
[HIV infected women with intense bone and muscular pain and general weakness].
    Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29, Issue:4

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Fanconi Syndrome; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Hypophosphatemia; Middle Aged; Muscle Weakness; Musculoskeletal Diseases; Organophosphonates; Osteomalacia; Pain; Radionuclide Imaging; Radiopharmaceuticals; Substance Abuse, Intravenous; Technetium Tc 99m Medronate; Tenofovir

2011
Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir.
    International journal of STD & AIDS, 2012, Volume: 23, Issue:1

    Topics: Adenine; Hepatitis B; Humans; Hypophosphatemia; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Vitamin D Deficiency

2012
Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir.
    HIV medicine, 2012, Volume: 13, Issue:9

    Topics: Adenine; Anti-HIV Agents; Calcium; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; HIV Seropositivity; Humans; Hypophosphatemia; Kidney Tubules, Proximal; Male; Middle Aged; Organophosphonates; Parathyroid Hormone-Related Protein; Phosphates; Tenofovir

2012
Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology.
    Antiviral therapy, 2013, Volume: 18, Issue:2

    Topics: Adenine; Anti-HIV Agents; Catalysis; Creatine Kinase, Mitochondrial Form; Enzyme Stability; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Hypophosphatemia; Organophosphonates; Protein Multimerization; Tenofovir

2013
Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases.
    Journal of acquired immune deficiency syndromes (1999), 2004, Mar-01, Volume: 35, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Drug Therapy, Combination; Female; Glycosuria; Humans; Hypophosphatemia; Kidney Tubules; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Proteinuria; Tenofovir; Treatment Outcome

2004
Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:6-7

    Topics: Adenine; Anti-HIV Agents; Drug Therapy, Combination; Fanconi Syndrome; HIV Infections; HIV-1; Humans; Hypophosphatemia; Kidney Tubules; Organophosphonates; Organophosphorus Compounds; Polyuria; Reverse Transcriptase Inhibitors; Tenofovir

2004
Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice.
    Journal of acquired immune deficiency syndromes (1999), 2005, Mar-01, Volume: 38, Issue:3

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Blood Chemical Analysis; Creatinine; Fanconi Syndrome; Female; HIV Infections; Humans; Hypophosphatemia; Lopinavir; Male; Organophosphonates; Phosphates; Prospective Studies; Pyrimidinones; Reproducibility of Results; Tenofovir; Urea

2005
Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.
    HIV medicine, 2005, Volume: 6, Issue:4

    Topics: Adenine; Adult; Anti-HIV Agents; Creatinine; Female; HIV Infections; Humans; Hypophosphatemia; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Organophosphonates; Proteinuria; Retrospective Studies; Risk Factors; Tenofovir; Urinalysis

2005
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
    HIV medicine, 2005, Volume: 6, Issue:5

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Fanconi Syndrome; Female; HIV Infections; Humans; Hypophosphatemia; Male; Middle Aged; Muscular Diseases; Organophosphonates; Osteomalacia; Reverse Transcriptase Inhibitors; Tenofovir

2005
Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.
    HIV medicine, 2006, Volume: 7, Issue:7

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Female; HIV Infections; Humans; Hypophosphatemia; Incidence; Male; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir; Treatment Outcome; United States

2006
[Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir].
    Medicina clinica, 2007, Jun-30, Volume: 129, Issue:5

    Topics: Adenine; Adult; Fractures, Bone; HIV Infections; Humans; Hypophosphatemia; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir

2007